Market failure and the poverty of new drugs in maternal health
- PMID: 18215109
- PMCID: PMC2211556
- DOI: 10.1371/journal.pmed.0050022
Market failure and the poverty of new drugs in maternal health
Abstract
A new survey finds that only 17 drugs are under active development for maternal health indications, which is less than 3% of the pipeline in cardiovascular health (660 drugs).
Conflict of interest statement
References
-
- Bartlett S. A-Z of medicines research. London: The Association of the British Pharmaceutical Industry; 2007.
-
- Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL. Prescription of drugs during pregnancy in France. Lancet. 2000;356:1735–1736. - PubMed
-
- Thornton J. The drugs we deserve. BJOG. 2003;110:969–970. - PubMed
-
- Peppin P. Manufacturing uncertainty: adverse effects of drug development for women. Int J Law Psychiatry. 2003;26:515–532. - PubMed
-
- Chalmers I, Enkin M, Keirse MJ, editors. Effective care in pregnancy and childbirth. Oxford: Oxford University Press; 1989.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
